In cancer-associated fibroblasts (CAFs), Kyn activates the AHR, leading to the activation of Protein Kinase B (AKT) and STAT3 signaling pathways, thereby promoting renal carcinoma progression and drug resistance [105]. Here, AKT1 is linked to renal carcinoma.